The FDA has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab ...

The increased stability from combining these proteins allowed the group to successfully generate monoclonal antibodies. The investigators determined which antibody was best able to specifically ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern University reports that NU-9, an experimental small-molecule drug currently ...

"By leveraging AI-based computational modeling, human organ model-based lab testing ... focuses on ending animal testing in regard to researching monoclonal antibody therapies, which are proteins made ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...